Ruoslahti, Erkki

Integrin signaling

Giancotti, F. G., & Ruoslahti, E. (1999) · Science

Cell Adhesion Molecules ResearchCellular Mechanics and Interactions

Cited by 3,869

RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS

Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology

Cell Adhesion Molecules ResearchBiochemical and Structural Characterization

Cited by 3,191

Binding of soluble form of fibroblast surface protein, fibronectin, to collagen

Engvall, E., & Ruoslahti, E. (1977) · International Journal of Cancer

Cell Adhesion Molecules ResearchCellular Mechanics and Interactions

Cited by 1,947

Negative regulation of transforming growth factor-β by the proteoglycan decorin

Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature

Proteoglycans and glycosaminoglycans researchTGF-β signaling in diseases

Cited by 1,516

C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences

Nanoparticle-Based Drug DeliveryAngiogenesis and VEGF in Cancer

Cited by 812

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

Okuda, S., Languino, L. R., Ruoslahti, E., & Border, W. A. (1990) · Journal of Clinical Investigation

Renal Diseases and GlomerulopathiesTGF-β signaling in diseases

Cited by 546

Brain extracellular matrix

Ruoslahti, E. (1996) · Glycobiology

Proteoglycans and glycosaminoglycans researchGlycosylation and Glycoproteins Research

Cited by 467

Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy

Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering

Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

Cited by 399

The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein– protein interactions independent of carbohydrate moiety

Aspberg, A., Miura, R., Bourdoulous, S., Shimonaka, M., Heinegård, D., Schachner, M., Ruoslahti, E., & Yamaguchi, Y. (1997) · Proceedings of the National Academy of Sciences

Proteoglycans and glycosaminoglycans researchGlycosylation and Glycoproteins Research

Cited by 275

Targeting atherosclerosis by using modular, multifunctional micelles

Peters, D., Kastantin, M., Kotamraju, V. R., Karmali, P. P., Gujraty, K., Tirrell, M., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences

Nanoparticle-Based Drug DeliveryAtherosclerosis and Cardiovascular Diseases

Cited by 271

Targeting tumor vasculature with homing peptides from phage display

Ruoslahti, E. (2000) · Seminars in Cancer Biology

Angiogenesis and VEGF in CancerNanoparticle-Based Drug Delivery

Cited by 157

Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles

Karmali, P. P., Chao, Y., Park, J.-H., Sailor, M. J., Ruoslahti, E., Esener, S. C., & Simberg, D. (2012) · Molecular Pharmaceutics

Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic Nanoparticles

Cited by 36